Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)
China
· Delayed Price · Currency is CNY 106.62
-0.39 (-0.36%)
Mar 9, 2026, 3:04 PM CST
SHE:300436 Revenue
Fujian Cosunter Pharmaceutical had revenue of 106.98M CNY in the quarter ending September 30, 2025, a decrease of -1.07%. This brings the company's revenue in the last twelve months to 430.98M, down -8.17% year-over-year. In the year 2024, Fujian Cosunter Pharmaceutical had annual revenue of 441.46M with 4.43% growth.
Revenue (ttm)
430.98M
Revenue Growth
-8.17%
P/S Ratio
39.40
Revenue / Employee
567.08K
Employees
760
Market Cap
16.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 441.46M | 18.74M | 4.43% |
| Dec 31, 2023 | 422.71M | 36.95M | 9.58% |
| Dec 31, 2022 | 385.77M | 15.32M | 4.14% |
| Jan 1, 2022 | 370.44M | 1.95M | 0.53% |
| Dec 31, 2020 | 368.49M | -46.38M | -11.18% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Medicine | 8.96B |
| Tonghua Dongbao Pharmaceutical | 2.74B |
| Shandong Buchang Pharmaceuticals | 10.96B |
| Shenzhen Kangtai Biological Products | 2.70B |
| Betta Pharmaceuticals | 3.26B |
| Nanjing King-Friend Biochemical Pharmaceutical | 3.76B |
| China Resources Jiangzhong Pharmaceutical Co.,Ltd | 4.24B |
| Walvax Biotechnology | 2.40B |